Tandem Diabetes (TNDM) EVP Rick Carpenter Receives 2,507 RSU Shares

What Happened
Rick Carpenter, EVP & Chief Technology Officer of Tandem Diabetes Care (TNDM), had RSUs vest on Aug 15, 2026. A total of 2,507 RSUs were converted into common shares (897 + 1,610). To satisfy tax withholding, the company withheld 1,277 shares (457 + 820) at $22.72 per share, totaling $29,013. No open-market sale occurred; net shares issued to Carpenter were 1,230.

Key Details

• Transaction date: 2026-08-15. Form 4 filed: 2026-08-18 (3 calendar days later). Note: Form 4 is generally due within two business days, so check timeliness if relevant.
• Conversion entries show $0 exercise price (RSU settlement); withholding entries priced at $22.72/share. Withheld amounts: $10,383 and $18,630 (total $29,013).
• Gross shares settled: 2,507. Shares withheld for taxes: 1,277. Net shares received: 1,230.
• Shares owned after the transaction are not specified in the provided excerpt.
• Relevant footnotes: F1 — shares withheld to satisfy tax withholding (no shares sold). F2–F6 — awards made under Tandem’s 2023 Long-Term Incentive Plan (awards dated May 23, 2024 and May 30, 2025) with specified vesting schedules.

Context

• These transactions reflect routine RSU vesting and share-for-tax withholding, not an open-market sale or a purchased stake. For retail investors, RSU settlements are compensation events and do not necessarily signal insider buying or selling intent.